Drug Profile
Tiapamil
Alternative Names: ORE 5002; tiapamil hydrochlorideLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Ore Pharmaceuticals
- Class Antiarrhythmics; Ischaemic heart disorder therapies; Propylamines; Small molecules
- Mechanism of Action Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported CNS disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in CNS-disorders in USA
- 31 Jul 2008 Preclinical trials in CNS disorders in USA (unspecified route)